Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor

References

• Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F10451482
   PubMed Web of Science ®Google Scholar
• Steben M, DuarteFranco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107(2):2–5. doi:10.1016/j.ygyno.2007.07.06717905139
   PubMedGoogle Scholar
• Hung CF, Ma B, Monie A, et al. Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin Biol Ther. 2008;8(4):421–439. doi:10.1517/14712598.8.4.42118352847
   PubMed Web of Science ®Google Scholar
• Bosch FX, Broker TR, Forman D, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31(8):1–31. doi:10.1016/j.vaccine.2013.07.026
   Google Scholar
• Yang A, Jeang J, Cheng K, et al. Current State in the development of candidate therapeutic HPV vaccines. Expert Rev Vaccines. 2016;15(8):989–1007. doi:10.1586/14760584.2016.115747726901118
   PubMed Web of Science ®Google Scholar
• Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–560. doi:10.1038/nrc288620592731
   PubMed Web of Science ®Google Scholar
• Einstein MH, Kadish AS, Burk RD, et al. Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecologic Oncology. 2007;106(3):453–460. doi:10.1016/j.ygyno.2007.04.03817586030
   PubMed Web of Science ®Google Scholar
• Hadeel K, Agnieszka G, Angelika R. Therapeutic vaccine strategies against human papillomavirus. Vaccines. 2014;2(2):422–462. doi:10.3390/vaccines202042226344626
   PubMedGoogle Scholar
• Rosalia RA, Cruz LJ, Duikeren SV, et al. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Biomaterials. 2015;40:88–97. doi:10.1016/j.biomaterials.2014.10.05325465442
   PubMed Web of Science ®Google Scholar
• Irvine DJ, Hanson MC, Rakhra K, et al. Synthetic nanoparticles for vaccines and immunotherapy. Chem Rev. 2015;115(19):11109–11146. doi:10.1021/cr500441926154342
   PubMed Web of Science ®Google Scholar
• Dimierpoisson I, Carpentier R, N’Guyen TT, et al. Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection. Biomaterials. 2015;50(1):164–175. doi:10.1016/j.biomaterials.2015.01.05625736506
   PubMedGoogle Scholar
• Chen W, Huang L. Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine. Mol Pharm. 2008;5(5):464–471. doi:10.1021/mp700126c18266319
   PubMedGoogle Scholar
• Thomas C, Rawat A, Hope-Weeks L, et al. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm. 2011;8(8):405–415. doi:10.1021/mp200125j21189035
   PubMedGoogle Scholar
• Negahdaripour M, Golkar N, Hajighahramani N, et al. Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biotechnol Adv. 2017;35(5):575–596. doi:10.1016/j.biotechadv.2017.05.00228522213
   PubMed Web of Science ®Google Scholar
• Whitesides GM, Grzybowski B. Self-assembly at all scales. Science. 2002;295(5564):2418–2421. doi:10.1126/science.107082111923529
   PubMed Web of Science ®Google Scholar
• Rad-Malekshahi M, Lempsink L, Amidi M, et al. Biomedical applications of self-assembling peptides. Bioconjug Chem. 2015;27(1):3–18. doi:10.1021/acs.bioconjchem.5b0048726473310
   PubMedGoogle Scholar
• Chesson CB, Huelsmann EJ, Lacek AT, et al. Antigenic peptide nanofibers elicit adjuvant-free CD8(+) T cell responses. Vaccine. 2014;32(10):1174–1180.24308959
   PubMed Web of Science ®Google Scholar
• Restuccia A, Tian YF, Collier JH, et al. Self-assembled glycopeptide nanofibers as modulators of galectin-1 bioactivity. Cell Mol Bioeng. 2015;8(3):471–487. doi:10.1007/s12195-015-0399-226495044
   PubMedGoogle Scholar
• Wen Y, Collier JH. Supramolecular peptide vaccines: tuning adaptive immunity. Curr Opin Immunol. 2015;35:73–79. doi:10.1016/j.coi.2015.06.00726163376
   PubMed Web of Science ®Google Scholar
• Mora-Solano C, Wen Y, Han H, et al. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers. Biomaterials. 2017;149:1–11. doi:10.1016/j.biomaterials.2017.09.03128982051
   PubMed Web of Science ®Google Scholar
• Chen J, Pompano RR, Santiago FW, et al. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials. 2013;34(34):8776–8785. doi:10.1016/j.biomaterials.2013.07.06323953841
   PubMed Web of Science ®Google Scholar
• Pompano RR, Chen J, Verbus EA, et al. Titrating T-Cell epitopes within self-assembled vaccines optimizes CD4+ Helper T cell and antibody outputs. Adv Healthc Mater. 2014;3(11):1898–1908. doi:10.1002/adhm.20140013724923735
   PubMedGoogle Scholar
• Rudra JS, Sun T, Bird KC, et al. Modulating adaptive immune responses to peptide self-assemblies. ACS Nano. 2012;6:1557–1564. doi:10.1021/nn204530r22273009
   PubMed Web of Science ®Google Scholar
• Sun T, Han H, Hudalla GA, et al. Thermal stability of self-assembled peptide vaccine materials. Acta Biomater. 2016;30:62–71. doi:10.1016/j.actbio.2015.11.01926584836
   PubMed Web of Science ®Google Scholar
• Luci C, Hervouet C, Rousseau D, et al. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B Subunit of cholera toxin. J Immunol. 2006;176(5):2749–2757. doi:10.4049/jimmunol.176.6.363516493030
   PubMedGoogle Scholar
• Choi B, Moon H, Hong SJ, et al. Effective delivery of antigen–encapsulin nanoparticle fusions to dendritic cells leads to antigen-specific cytotoxic T cell activation and tumor rejection. ACS Nano. 2016;10(8):7339–7350. doi:10.1021/acsnano.5b0808427390910
   PubMed Web of Science ®Google Scholar
• Si Y, Wen Y, Kelly SH, et al. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses. J Control Release. 2018;28:120–130. doi:10.1016/j.jconrel.2018.04.031
   Google Scholar
• Kennedy R, Celis E. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev. 2008;222(1):129–144. doi:10.1111/j.1600-065X.2008.00616.x18363998
   PubMedGoogle Scholar
• Wang S, Huang W, Li K, et al. Engineered outer membrane vesicle is potent to elicit HPV16 E7-specific cellular immunity in a mouse model of TC-1 graft tumor. Int J Nanomedicine. 2017;12:6813–6825. doi:10.2147/IJN.S14326428979120
   PubMedGoogle Scholar
• Karch CP, Burkhard P. Vaccine technologies: from whole organisms to rationally designed protein assemblies. Biochem Pharmacol. 2016;120:1–14. doi:10.1016/j.bcp.2016.05.00127157411
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–1964. doi:10.1126/science.112913917008531
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ju S, Chen E, et al. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol. 2010;185(6):3174–3183. doi:10.4049/jimmunol.100074920713880
   PubMed Web of Science ®Google Scholar
• Zou W. Regulatory T cells, tumor immunity and immunotherapy. Nat Rev Immunol. 2006;6(4):295–307. doi:10.1038/nri180616557261
   PubMed Web of Science ®Google Scholar
• Huang ZH, Shi L, Ma JW, et al. A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy. J Am Chem Soc. 2012;134(21):8730. doi:10.1021/ja211725s22587010
   PubMed Web of Science ®Google Scholar
• Azmi F, Ahmad Fuaad AA, Giddam AK, et al. Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant. Bioorg Med Chem. 2014;22(22):6401–6408. doi:10.1016/j.bmc.2013.11.00525438764
   PubMed Web of Science ®Google Scholar